KUALA LUMPUR: Duopharma Biotech Bhd
aims for a 10% revenue growth this year, up from RM704.73mil achieved in the financial year ended Dec 31, 2023.
Group managing director Leonard Ariff Abdul Shatar said the higher target for 2024 would be driven by both public and export portfolios.
